Antibiotics discovery in 1940's was considered one of the most outstanding medical achievements that saved millions of people and animals lives worldwide. Unfortunately misuse and overuse of antibiotics led inevitably to the emergence and spreading of Antimicrobial resistance. If no action is taken to tackle it by 2050, Antimicrobial resistance will cause the death of 10 million lives a year. The fact that very few antibiotics are introduced into the market in the new millennia means that designing new strategies to extend the useful life of available antibiotics has become a priority. Therefore, new strategies such as the inactivation of residual antibiotics are investigated to protect the intestinal and environmental microbiota against harmful impact of residual antibiotics.
I'm a motivated pharmacist, graduated from the University of Jordan in 2017. After I graduated I worked in community pharmacies, private and public hospitals as I was eager to gain insight into different worlds of healthcare sectors. In 2019 I completed my MSc in pharmaceutical sciences and management studies at Kingston University. I learnt lots of new skills which have enhanced my research and practical skills and I became more passionate to do more research in the pharmaceutical field. I have therefore decided to join Kingston University as a PhD student in 2021.